CasPEDIA Database: a functional classification system for class 2 CRISPR-Cas enzymes

Benjamin A. Adler(QB3), Marena Trinidad(Howard Hughes Medical Institute), Daniel Bellieny‐Rabelo(QB3), Elaine Zhang(Howard Hughes Medical Institute), Hannah Karp(Innovative Genomics Institute), Petr Skopintsev(QB3), Brittney W. Thornton(Innovative Genomics Institute), Rachel F. Weissman(Innovative Genomics Institute), Peter H. Yoon(Innovative Genomics Institute), Lin-Xing Chen(Planetary Science Institute), Tomas Hessler(Planetary Science Institute), Amy R. Eggers(Innovative Genomics Institute), David Colognori(Innovative Genomics Institute), Ron Boger(QB3), Erin Doherty(QB3), Connor A. Tsuchida(University of California, San Francisco), Ryan Tran(University of California, Berkeley), Laura Hofman(QB3), Honglue Shi(Howard Hughes Medical Institute), Kevin Wasko(Innovative Genomics Institute), Zehan Zhou(Innovative Genomics Institute), Chenglong Xia(QB3), Muntathar Al-Shimary(Innovative Genomics Institute), Jaymin R. Patel(Innovative Genomics Institute), Vienna Thomas(Innovative Genomics Institute), Rithu Pattali(Innovative Genomics Institute), Matthew J. Kan(University of California, San Francisco), Anna Vardapetyan(Innovative Genomics Institute), Alana Yang(Innovative Genomics Institute), Arushi Lahiri(University of California, Berkeley), Micaela F Maxwell(Hampton University), Andrew G. Murdock(Innovative Genomics Institute), Glenn C Ramit(Innovative Genomics Institute), Hope R. Henderson(Innovative Genomics Institute), Roland W. Calvert(Monash University), Rebecca S. Bamert(Monash University), Gavin J. Knott(Monash University), Audronė Lapinaitė(Arizona State University), Patrick Pausch(Vilnius University), Joshua C. Cofsky(Harvard University), Erik J. Sontheimer(University of Massachusetts Chan Medical School), Blake Wiedenheft(Montana State University), Peter C. Fineran(Maurice Wilkins Centre), Stan J. J. Brouns(Delft University of Technology), Dipali G. Sashital(Iowa State University), Brian C. Thomas, Christopher T. Brown, Daniela S. Aliaga Goltsman, Rodolphe Barrangou(North Carolina State University), Virginius Siksnys(Vilnius University), Jillian F. Banfield(Planetary Science Institute), David F. Savage(Howard Hughes Medical Institute), Jennifer A. Doudna(QB3)
Nucleic Acids Research
October 27, 2023
Cited by 36Open Access
Full Text

Abstract

CRISPR-Cas enzymes enable RNA-guided bacterial immunity and are widely used for biotechnological applications including genome editing. In particular, the Class 2 CRISPR-associated enzymes (Cas9, Cas12 and Cas13 families), have been deployed for numerous research, clinical and agricultural applications. However, the immense genetic and biochemical diversity of these proteins in the public domain poses a barrier for researchers seeking to leverage their activities. We present CasPEDIA (http://caspedia.org), the Cas Protein Effector Database of Information and Assessment, a curated encyclopedia that integrates enzymatic classification for hundreds of different Cas enzymes across 27 phylogenetic groups spanning the Cas9, Cas12 and Cas13 families, as well as evolutionarily related IscB and TnpB proteins. All enzymes in CasPEDIA were annotated with a standard workflow based on their primary nuclease activity, target requirements and guide-RNA design constraints. Our functional classification scheme, CasID, is described alongside current phylogenetic classification, allowing users to search related orthologs by enzymatic function and sequence similarity. CasPEDIA is a comprehensive data portal that summarizes and contextualizes enzymatic properties of widely used Cas enzymes, equipping users with valuable resources to foster biotechnological development. CasPEDIA complements phylogenetic Cas nomenclature and enables researchers to leverage the multi-faceted nucleic-acid targeting rules of diverse Class 2 Cas enzymes.


Related Papers

No related papers found

Powered by citation graph analysis